MedPath

黑龙江瑞格制药有限公司

Ownership
-
Established
2003-07-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

86

NMPA:86

Drug Approvals

Notoginseng,Ginseng and Amino Acid Capsules

Product Name
田参氨基酸胶囊
Approval Number
国药准字H20041490
Approval Date
Jan 3, 2025
NMPA

Nimesulide Granules

Product Name
茂欣
Approval Number
国药准字H20041489
Approval Date
Jan 3, 2025
NMPA

Nimesulide Granules

Product Name
茂欣
Approval Number
国药准字H20041488
Approval Date
Jan 3, 2025
NMPA

Baicalin

Product Name
黄芩苷
Approval Number
国药准字H23023077
Approval Date
Dec 11, 2023
NMPA

Berberine Hydrochloride and Trimethoprim Capsules

Product Name
小檗碱甲氧苄啶胶囊
Approval Number
国药准字H20033978
Approval Date
Aug 21, 2021
NMPA

Inosine Oral Solution

Product Name
肌苷口服液
Approval Number
国药准字H19993354
Approval Date
Jul 26, 2020
NMPA

Diazepam Tablets

Product Name
地西泮片
Approval Number
国药准字H23020043
Approval Date
Jul 22, 2020
NMPA

消栓口服液

Approval Number
国药准字Z23020058
Approval Date
Jul 22, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H23020044
Approval Date
Jul 22, 2020
NMPA

Compound Fluorouracil Oral Solution

Product Name
复方氟尿嘧啶口服溶液
Approval Number
国药准字H23023199
Approval Date
Jul 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.